MATK, in the high expression group, demonstrated substantial enrichment in autoimmune thyroid disease, whereas in the low expression group, the chemokine signaling pathway exhibited predominant enrichment of MATK (Fig. 6C1, C2). Here, MATK is linked to autoimmune thyroid disease.